Cargando…

The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis

BACKGROUND: NSAIDs are accepted as the most predictably efficacious medical treatment of the clinical signs of osteoarthritis (OA). The marine-based fatty-acid compound PCSO-524 has been proposed as an adjunctive treatment for canine OA, however benefits of this agent is still controversial. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vijarnsorn, Monchanok, Kwananocha, Irin, Kashemsant, Narudee, Jarudecha, Thitichai, Lekcharoensuk, Chalermpol, Beale, Brian, Peirone, Bruno, Lascelles, B. Duncan X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798752/ https://www.ncbi.nlm.nih.gov/pubmed/31623621 http://dx.doi.org/10.1186/s12917-019-2110-7

Ejemplares similares

Correction to: The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2020)

In Vitro Anti-Inflammatory and Regenerative Effects of Autologous Conditioned Serum from Dogs with Osteoarthritis
por: Soontararak, Sirikul, et al.
Publicado: (2022)

Testing the Neuroprotective Properties of PCSO-524(®) Using a Neuronal Cell Cycle Suppression Assay
por: Zhu, Beika, et al.
Publicado: (2019)

Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: A prospective, block-randomized, double-blinded, placebo-controlled clinical trial
por: Kampa, Naruepon, et al.
Publicado: (2023)

Corrigendum: Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis: a prospective, block-randomized, double-blinded, placebo-controlled clinical trial
por: Kampa, Naruepon, et al.
Publicado: (2023)

Use of firocoxib for the treatment of equine osteoarthritis
por: Donnell, Josh R, et al.
Publicado: (2014)

Perna canaliculus Lipid Complex PCSO-524™ Demonstrated Pain Relief for Osteoarthritis Patients Benchmarked against Fish Oil, a Randomized Trial, without Placebo Control
por: Zawadzki, Marek, et al.
Publicado: (2013)

The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
por: SHEI, REN-JAY, et al.
Publicado: (2018)

Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors
por: Brandi, Andressa, et al.
Publicado: (2022)

Analgesic efficacy of oral firocoxib in ovariohysterectomized cats
por: Phuwapattanachart, Prangtip, et al.
Publicado: (2017)

Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial
por: Kean, James D., et al.
Publicado: (2016)

Possibility of Using House Cricket (Acheta domesticus) or Mulberry Silkworm (Bombyx mori) Pupae Meal to Replace Poultry Meal in Canine Diets Based on Health and Nutrient Digestibility
por: Areerat, Sathita, et al.
Publicado: (2021)

Insect-based diets (house crickets and mulberry silkworm pupae): A comparison of their effects on canine gut microbiota
por: Areerat, Sathita, et al.
Publicado: (2023)

Synopsis of the pharmacokinetics, pharmacodynamics, applications, and safety of firocoxib in horses
por: Fadel, Charbel, et al.
Publicado: (2023)

Safety Assessment of an Oral Therapeutic Dose of Firocoxib on Healthy Horses
por: Araújo, Renatha A., et al.
Publicado: (2023)

Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses
por: White, Julianne M., et al.
Publicado: (2023)

Cutaneous adverse drug reaction in a dog following firocoxib treatment
por: Geum, Migyeong, et al.
Publicado: (2021)

Molecular identification of Trichuris trichiura and Hymenolepis diminuta in long-tailed macaques (Macaca fascicularis) in Lopburi, Thailand
por: Sricharern, Wanat, et al.
Publicado: (2021)

The effects PCSO-524®, a patented marine oil lipid and omega-3 PUFA blend derived from the New Zealand green lipped mussel (Perna canaliculus), on indirect markers of muscle damage and inflammation after muscle damaging exercise in untrained men: a randomized, placebo controlled trial
por: Mickleborough, Timothy D, et al.
Publicado: (2015)

Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment
por: Delsart, Aliénor, et al.
Publicado: (2022)

Genetic characterization of porcine circovirus type 2 in piglets from PMWS-affected and -negative farms in Thailand
por: Jantafong, Tippawan, et al.
Publicado: (2011)

Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
por: de Salazar Alcalá, Andrea García, et al.
Publicado: (2019)

Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma
por: OSADA, Hironari, et al.
Publicado: (2023)

The effect of spontaneous osteoarthritis on conditioned pain modulation in the canine model
por: Chiu, King Wa, et al.
Publicado: (2020)

Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses
por: Theerawatanasirikul, Sirin, et al.
Publicado: (2020)

Risk factors and clinical and laboratory findings associated with feline immunodeficiency virus and feline leukemia virus infections in Bangkok, Thailand
por: Rungsuriyawiboon, Oumaporn, et al.
Publicado: (2022)

Hemostatic Markers in Congestive Heart Failure Dogs with Mitral Valve Disease
por: Prihirunkit, Kreangsak, et al.
Publicado: (2014)

Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
por: de Salazar Alcalá, Andrea García, et al.
Publicado: (2019)

Widespread somatosensory sensitivity in naturally occurring canine model of osteoarthritis
por: Knazovicky, David, et al.
Publicado: (2016)

Séminaire Bourbaki : exposés 507–524
por: Dold, A, et al.
Publicado: (1979)

Using bioelectrical impedance analysis for modeling regression and predicting body fat accumulation in dogs in East Thailand
por: Arreesrisom, Peera, et al.
Publicado: (2022)

First study on stress evaluation and reduction in hospitalized cats after neutering surgery
por: Klintip, Worranan, et al.
Publicado: (2022)

Initial evaluation of nighttime restlessness in a naturally occurring canine model of osteoarthritis pain
por: Knazovicky, David, et al.
Publicado: (2015)

A Novel Plasmid DNA-Based Foot and Mouth Disease Virus Minigenome for Intracytoplasmic mRNA Production
por: Semkum, Ploypailin, et al.
Publicado: (2021)

Improvement of the Firocoxib Dissolution Performance Using Electrospun Fibers Obtained from Different Polymer/Surfactant Associations
por: Maggi, Lauretta, et al.
Publicado: (2019)

Comparaison de la jauge NRC 524
por: Dubler, H
Publicado: (1969)

524 Reccurent Wheezing in Childhood—Is It Always Asthma?
por: Muti, Andrea Daniela, et al.
Publicado: (2012)

524 Traveling Pediatric Burn Care on Wheels
por: Pruitt, Mary, et al.
Publicado: (2023)

Isolation of Oral Bacteria, Measurement of the C-Reactive Protein, and Blood Clinical Parameters in Dogs with Oral Tumor
por: Setthawongsin, Chanokchon, et al.
Publicado: (2023)

Minimal clinically-important differences for the ‘Liverpool Osteoarthritis in Dogs’ (LOAD) and the ‘Canine Orthopedic Index’ (COI) client-reported outcomes measures
por: Innes, John F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rcot3au21m2vefm9e2dfmggimb